Abstract:Protein Arginine Methyltransferases (PRMTs) are a family of enzymes regulating protein arginine methylation, which is a post-translational modification crucial for various cellular processes. Recent studies have highlighted the mechanistic role of PRMTs in cancer pathogenesis, immunotherapy, and drug resistance. PRMTs are involved in diverse oncogenic processes, including cell proliferation, apoptosis, and metastasis. They exert their effects by methylation of histones, transcription factors, and other regulatory proteins, resulting in altered gene expression patterns. PRMT-mediated histone methylation can lead to aberrant chromatin remodeling and epigenetic changes that drive oncogenesis. Additionally, PRMTs can directly interact with key signaling pathways involved in cancer progression, such as the PI3K/Akt and MAPK pathways, thereby modulating cell survival and proliferation. In the context of cancer immunotherapy, PRMTs have emerged as critical regulators of immune responses. They modulate immune checkpoint molecules, including programmed cell death protein 1 (PD-1), through arginine methylation. Drug resistance is a significant challenge in cancer treatment, and PRMTs have been implicated in this phenomenon. PRMTs can contribute to drug resistance through multiple mechanisms, including the epigenetic regulation of drug efflux pumps, altered DNA damage repair, and modulation of cell survival pathways. In conclusion, PRMTs play critical roles in cancer pathogenesis, immunotherapy, and drug resistance. In this overview, we have endeavored to illuminate the mechanistic intricacies of PRMT-mediated processes. Shedding light on these aspects will offer valuable insights into the fundamental biology of cancer and establish PRMTs as promising therapeutic targets.

Correlation of protein arginine methyltransferase with the occurrence and development of malignancy

PRMT1 in human neoplasm: cancer biology and potential therapeutic target

Protein Arginine Methyltransferases (PRMTs): Orchestrators of Cancer Pathogenesis, Immunotherapy Dynamics, and Drug Resistance

Dysregulation of arginine methylation in tumorigenesis

The Role of PRMT1 in Cellular Regulation and Disease: Insights into Biochemical Functions and Emerging Inhibitors for Cancer Therapy

Protein Arginine Methyltransferase 5: a Potential Cancer Therapeutic Target

The methylation induced by protein arginine methyltransferase 5 promotes tumorigenesis and progression of lung cancer

The Methylation Induced by Protein Arginine Methyltransferase 5 Promotes Tumorigenesis and Progression of Lung Cancer.

Protein arginine methylation: from enigmatic functions to therapeutic targeting

Protein arginine methyltransferases: promising targets for cancer therapy

Protein arginine methylation of non-histone proteins and its role in diseases.

Research progress on PRMTs involved in epigenetic modification and tumour signalling pathway regulation (Review)

Protein Arginine Methylation: An Emerging Modification in Cancer Immunity and Immunotherapy

PRMT5 in gene regulation and hematologic malignancies

Overview of PRMT1 modulators: Inhibitors and degraders

PRMT5 prognostic value in cancer

The role of protein arginine methylation 5 in DNA damage repair and cancer therapy

The regulation, functions and clinical relevance of arginine methylation

Automethylation of Protein Arginine Methyltransferase 7 and Its Impact on Breast Cancer Progression

PRMT5: a putative oncogene and therapeutic target in prostate cancer

Table S1 from the Role of Protein Arginine Methyltransferases in Pathogenesis and Treatment of Digestive System Carcinoma